Stay updated on Lumateperone Monotherapy in Bipolar/Major Depressive Disorder Clinical Trial
Sign up to get notified when there's something new on the Lumateperone Monotherapy in Bipolar/Major Depressive Disorder Clinical Trial page.

Latest updates to the Lumateperone Monotherapy in Bipolar/Major Depressive Disorder Clinical Trial page
- ChecktodayChange DetectedThe NCT04285515 page now displays the study record for a completed Phase 3 trial of lumateperone for bipolar depression or major depressive disorder, including its eligibility criteria, study design, outcomes, and posted results.SummaryDifference59%

- Check7 days agoChange DetectedThe footer’s ClinicalTrials.gov revision identifier changed from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check14 days agoChange DetectedA sitewide NIH banner announces website-transition updates and says NIH content may use “Super Intelligence” (SI) in place of “Artificial Intelligence” (AI).SummaryDifference1%

- Check21 days agoChange DetectedThe site's revision identifier changes from v3.7.1 to v3.7.2 while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check28 days agoChange DetectedThe footer revision label changed from v3.7.0 to v3.7.1 on the 403 error page.SummaryDifference0.2%

- Check49 days agoChange DetectedThe page now displays a 403 error page instead of the study record content. This reflects an access issue rather than an update to the study data.SummaryDifference17%

Stay in the know with updates to Lumateperone Monotherapy in Bipolar/Major Depressive Disorder Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lumateperone Monotherapy in Bipolar/Major Depressive Disorder Clinical Trial page.